Andrei Medvedovici

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The metabolic processes frequently trigger highly complex pharmacokinetic (PK) and pharmacodynamic (PD) characteristics for the coexisting entities, parent drug and its active or inactive metabolites. The interpretation of both individual and cumulative profiles, frequently used in the therapeutic drug monitoring procedures, must take into consideration the(More)
  • 1